Medical / Pharmaceuticals
Releases published in the last 30 days. 
Page 1 of 2
- Availability of the aide-mémoire for Q2 2026 results
- 7/2/2026 10:41:05 AM
- Sanofi announced the availability of the aide-mémoire for Q2 2026 results on the “Investors” page of sanofi.com: Second quarter 2026 results Prepared each quarter, this document is intended to support financial modelling of the quarterly results.
- Enhertu approved in the EU as first tumour agnostic HER2-directed therapy and antibody drug conjugate for patients with previously treated HER2-positive metastatic solid tumours
- 7/2/2026 10:39:00 AM
- AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been approved in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2-positive (immunohistochemistry [IHC] 3+) solid tumours who have received prior treatment and who have no satisfactory treatment options.
- Sanofi’s Nexviazyme met all primary and secondary endpoints in infantile-onset Pompe disease phase 3 study
- 6/30/2026 1:28:38 PM
- • Nexviazyme met its primary endpoint, participants alive and free of invasive ventilation, in treatment-naïve infants zero to six months of age in the Baby-COMET phase 3 study • Sanofi intends to submit the data to support a regulatory application in the US for the treatment of infantile-onset Pompe disease Positive results from the Baby-COMET phase 3, …
- Forty-ninth session of the FAO/WHO Codex Alimentarius Commission adopts new standards
- 6/29/2026 8:41:16 AM
- The 49th session of the Codex Alimentarius Commission (CAC49) will be held 6–10 July 2026 in Geneva, Switzerland. The plenary sessions will be webcast in all six UN languages (Arabic, Chinese, English, French, Russian and Spanish).
- Prior authorization reform gets promising start from House health panel
- 6/29/2026 8:04:05 AM
- Statement is attributable to: John Whyte, MD, MPH CEO, American Medical Association “The American Medical Association commends the House Energy and Commerce Health Subcommittee for its swift action today to advance the Improving Seniors’ Timely Access to Care Act.
- Telehealth and Medicine Today Publishes June 2026 Issue on AI, Market Shifts, and Care Transformation
- 6/29/2026 8:00:00 AM
- Telehealth and Medicine Today (THMT), a SCImago Q2 ranked journal, announces the release of its June 2026 issue, presenting a new collection of research, market intelligence, and expert perspectives at the forefront of telehealth, artificial intelligence, and digital health transformation.
- Sanofi Foundation opens new chapter centered on future generations
- 6/25/2026 1:04:01 PM
- The Sanofi Foundation is opening a new chapter with a strengthened commitment to children and young people, particularly those living with serious diseases.
- Socioeconomic Challenges Color Patients’ Lung Cancer Screening Experience
- 6/24/2026 11:00:53 AM
- New research among lung cancer screening participants has found that low-dose chest computed tomography (CT) screening is generally well tolerated both physically and emotionally, but experiences vary across socioeconomic groups.
- Sanofi’s Wayrilz approved in Japan to treat immune thrombocytopenia
- 6/23/2026 11:23:27 AM
- • Wayrilz is a BTK inhibitor that works through multi-immune modulation to help address the underlying causes of immune thrombocytopenia (ITP) • Approval based on the LUNA 3 phase 3 study that demonstrated rapid and durable platelet response and improvements in other symptoms • ITP is a rare disease of complex immune dysregulation leading to lower platelet counts, …
- Are certain demographic, birth, and parental characteristics linked to an increased risk of early-onset colorectal cancer?
- 6/23/2026 10:57:24 AM
- A recent study found that factors such as a person’s birthweight, sex, ethnicity, and father’s age may affect the risk of being diagnosed with colorectal cancer at a young age.
- Sanofi appoints Paulo Fontoura as Global Head of R&D
- 6/22/2026 7:21:08 PM
- Sanofi today announced the appointment of Paulo Fontoura, MD, PhD, FAAN, as Executive Vice President, Global Head of Research & Development Pharma, effective September 1, 2026.
- AdvaMed Earns WTOP News Regional Top Workplaces 2026 Award, Culture Excellence Awards
- 6/22/2026 8:27:24 AM
- AdvaMed, the largest trade association representing medtech innovators, announced it is a WTOP News Top Workplaces 2026 award winner in the Washington, D.C., region and received five Culture Excellence awards.
- Senate panel passes NO FAKES Act; AMA urges Congressional approval
- 6/22/2026 8:16:18 AM
- Statement attributable to: John Whyte, MD, MPH CEO, American Medical Association “The NO FAKES Act is the real deal—an important step toward ensuring that innovation serves people, not those seeking to deceive them.
- Vali Health Raises $6M to Build Responsible AI Infrastructure for Home Care Agencies
- 6/17/2026 9:35:05 AM
- Vali Health, a startup building responsible AI infrastructure for the home care industry, today emerged from stealth with $6 million in funding from Bonfire Ventures, Supernode, Comma Capital, along with Jacquelyn Kung, an industry veteran who built two of the largest software platforms for home care.
- Heartseed Announces First Patient Dosed in a Phase I/II EMERALD Study with HS-005 – a Cell Therapy Administered via Catheter, Designed to Restore Heart Function in People with Severe Heart Failure
- 6/15/2026 12:16:05 PM
- Nikon CeLL innovation Co., Ltd. (NCLi), a subsidiary of Nikon Corporation (Nikon), manufactures iPSC-derived purified cardiomyocyte spheroids of HS-005, under contract to Heartseed Inc.(Heartseed).
- CONV2X Announces Smart Technology Transformation in Healthcare & Life Sciences Summit in New York City
- 6/15/2026 10:56:45 AM
- CONV2X Smart Technology Transformation in Healthcare & Life Sciences, announced its annual two-day executive summit taking place October 29–30, 2026 at the Historic GE Building, ILR Conference Center, 570 Lexington Avenue, New York, NY.
- Elsevier launches Ebola Information Center with free clinical and research resources to support response to outbreak
- 6/15/2026 10:54:14 AM
- Following the World Health Organization’s declaration of an Ebola outbreak caused by Bundibugyo virus in the Democratic Republic of Congo and Uganda as a Public Health Emergency of International Concern (PHEIC), Elsevier, a global leader in scientific information and analytics, has launched its Ebola Information Center to provide healthcare professionals, researchers, …
- Ultomiris granted Priority Review in the US as treatment for adults with immunoglobulin A nephropathy
- 6/15/2026 10:48:37 AM
- Based on I CAN Phase III trial results from prespecified interim analysis in which Ultomiris demonstrated 43.4% reduction in proteinuria vs placebo at 34 weeks If approved, Ultomiris would be the first C5 complement inhibitor available for this rare kidney disease Alexion, AstraZeneca Rare Disease’s supplemental Biologics License Application (sBLA) for …
- Caring for non-communicable diseases during pregnancy, expert convening
- 6/15/2026 10:36:28 AM
- The World Health Organization (WHO) is developing new recommendations to improve care for pregnant and postpartum women living with noncommunicable diseases (NCDs).
- “Beyond Feet on Fire” is Free to Download for Only Five Days (Until 6/19/26)
- 6/15/2026 6:00:00 AM
- Best Seller Publishing announces the release of Dr. Paul Fisher’s new book, “Beyond Feet on Fire: How To Reverse Neuropathy Without Drugs and Surgery.” It will be available in the Amazon store for free for only five days.